Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials
Target(TGT) Thenewswire·2025-05-08 21:00Calgary, Alberta – TheNewswire - May 8, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce a significant breakthrough in its development of next-generation intraocular lens technology. In recent laboratory testing, the Company successfully demonstrated accommodative power change using 3D-printed moulded lenses under simulated ciliary body compression conditions - marking a pivotal step f ...